S&PTELECONF: Request For Comment: Public And Nonprofit Social Housing Providers; Mon. Jan. 9, 2012@2:00 PM EST Jan 12

  • ID: 2038990
  • January 2012
  • Standard & Poors
1 of 2

NEW YORK (Standard & Poor's) Jan. 5, 2012-- Standard & Poor's Ratings Services is requesting comments on its proposed changes to its methodology and assumptions for rating social or public housing providers globally. Our proposal and the specific requests we are making are outlined in the article, "Public And Nonprofit Social Housing Providers: Methodology And Assumptions." Please join Valerie White, senior director, U.S. Public Finance Ratings, on Monday, Jan. 9, 2012, at 2:00 p.m. Eastern Standard Time for a complimentary, live teleconference and Q&A to discuss Standard & Poor's proposed criteria. The assignment of issuer credit ratings (ICRs) for social or public housing providers begins with an assessment of the provider's stand-alone credit profile (SACP). This proposal is limited to...

Action: Teleconferences

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.